bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.08.25.505363

HIV-1 GAG SPECIFICITY FOR PIP2-CONTAINING MEMBRANES MIGHT BE DRIVEN BY MACROMOLECULAR ELECTRIC PROPERTIES RATHER THAN MOLECULAR AFFINITIES

Abstract

The HIV-1 assembly occurs at the plasma membrane, where the GAG polyprotein plays a crucial role. The GAG-membrane association is directed by the matrix domain (MA), which is myristoylated and has a highly basic region that interacts with the anionic lipids. Several evidence suggests that the presence of phosphatidylinositol-(4,5)-bisphosphate (PIP2) highly influence this binding. In addition, MA also interacts with nucleic acids, which is proposed to be important for the specificity of GAG for PIP2-containing membranes. It is proposed that RNA could have a chaperone function when interacting with the MA domain, preventing GAG from associating with unspecific lipid interfaces. Here, we study the interaction of MA with monolayer and bilayer membrane systems, focused on the specificity for PIP2 and on the possible effects of a GAG N-terminal peptide to impair the binding for either RNA or membrane. We found that RNA decreases the kinetics of the protein association with lipid monolayers but without any effect on the selectivity for PIP2. Interestingly, for bilayer systems, this selectivity increases in presence of both the peptide and RNA, even for highly negative charged compositions, where MA by itself doesnt discriminate between membranes with or without PIP2. Therefore, we propose that the specificity of MA for PIP2-membranes might be related to the electrostatic properties of both membrane and protein local environments, rather than a simple difference in molecular affinities. This scenario gives a new understanding of the regulation mechanism with a macromolecular view instead of considering molecular interactions within a ligand-receptor model. ImportanceHIV-1 virions are formed at the PM of infected cells through a direct interaction of the viral GAG protein with lipids. This is a finely regulated process governed by the GAG N-terminal matrix domain, MA. Here, we obtained compelling evidence on how this process depends on the local dielectric environments of both, the membrane and MA. Using bio-membrane mimicking systems, we found how MA myristoylation is involved in the interfacial absorption and anchoring of the protein, where the interaction with RNA negatively regulates this process but in a lesser extent when traces of the PIP2 lipid are present. Additionally, an N-terminal GAG-derived peptide competes with MA for the nucleic acid binding and impair the protein-membrane interaction when PIP2 is absent. All these data allowed us to propose a model for MA association with lipid interfaces and how it depends on oligonucleotide binding, lipid composition and competing peptide presence.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Perez Socas, L. B., Ambroggio, E. E.. 2022-08-26. HIV-1 GAG SPECIFICITY FOR PIP2-CONTAINING MEMBRANES MIGHT BE DRIVEN BY MACROMOLECULAR ELECTRIC PROPERTIES RATHER THAN MOLECULAR AFFINITIES. https://doi.org/10.1101/2022.08.25.505363

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Sequence context and partner availability specify divergent cell fates from a single transcription factor

Transcription factors drive the gene regulatory networks that control developmental transitions, yet which of their many targets a cell uses remains unresolved. Expressing Cebp, Cebp{beta} or Cebp{delta} identically, alone or with Oct4, Sox2, Klf4 and cMyc, gave four outcomes: adipocyte from fibroblasts and neural stem cells, trophectoderm from embryonic stem cells, and myeloid from B cells. Raising Cebp levels changed how many sites it reached, not which sequence it read: clustered motifs maintained somatic enhancers, while spillover onto low-copy sites created de novo enhancers carrying composites of Cebp and cell-type-restricted partners. In fibroblasts, Cebp also redistributed Oct4, Sox2 and Klf4 from early targets, blocking iPSC formation. Supplying the predicted partners rewrote the output: Spi1 redirected Cebp into parallel adipogenic and myeloid programs, via a transient PpargCD45 state using separate enhancers for each; TFAP2C abolished adipogenic conversion. Motif density and partner composites therefore assemble a factor's instructive output in the receiving cell.

cell biology↗

Tracking the conformational dynamics of single molecules in live cells; GTPase cycling in Cdc42 gradients and microclusters

The Rho family of GTPases play a critical role in many cellular processes by acting as molecular switches relying on conformational changes to transition between active and inactive states. The spatial distribution and kinetics of these conformational changes are complex and vary across the cell. We describe here biosensors based on environment-responsive fluorescent dyes, capable of reporting the conformational changes of individual GTPase molecules as they traffic within living cells (SPARC Cdc42 and SPARC Rac1, 'Single Particle Activation Reporter Constructs'). We use SPARC Cdc42 to determine the rates of different steps in GTPase regulation, activation/inactivation and membrane insertion, that together generate localized gradients of Cdc42 activity driving cell motility. The biosensors also revealed heterogeneously distributed clusters of Cdc42, the mechanisms of their activation, and potential roles in polarized motility.

cell biology↗

High-content screening identifies FDA-approved activators of mitophagy

Mitochondrial diseases are highly heterogeneous disorders caused by defects in oxidative phosphorylation, for which only limited therapeutic options are available. The elimination of dysfunctional mitochondria via mitophagy activation is an attractive strategy to treat several mitochondrial diseases, irrespective of the underlying genetic defect. To identify pharmacological activators of this pathway, we performed a high-content screening of 1,971 FDA-approved compounds using cellular reporters of TFEB nuclear translocation and mitophagy. This screening identified 294 compounds that promoted TFEB translocation, nine of which increased the number of mitolysosomes without compromising cell viability or damaging mitochondria. Among the selected compounds, Meptazinol and Ponatinib emerged as the top-ranked mitophagy inducers in fibroblasts from patients with complex I and IV deficiency, respectively, and were prioritised for further characterisation. However, they did not rescue the bioenergetic defect, suggesting that the stimulation of mitophagy per se is not sufficient to ameliorate the OXPHOS defect in mitochondrial diseases. Overall, our findings establish a scalable platform for the identification of pharmacological activators of TFEB and identify candidate compounds for therapeutic modulation of mitophagy.

cell biology↗